Radiant Research, Inc., a leading provider of clinical and consumer product testing, has expanded its consumer division.
Radiant Research, Inc., a leading provider of clinical and consumer product testing, has expanded its consumer division. This expansion includes additional geographic locations and increased product testing capabilities. The changes give Radiant’s consumer testing sites the ability to conduct studies in more diverse dermatological disease states, as well as in a varied demographical healthy normal population, with new bioinstrumentation resources.
“Radiant has become an industry leader in complex consumer trials since launching this specialized division in 2011,” said Tara Kelley, vice president of operations for Radiant Research. “Now, we’re giving our clients more options for their consumer testing needs by adding new locations and specialty populations. We’ve also made the process more efficient by integrating our consumer product and clinical trial database – giving us access to one million potential study participants.”
As part of its commitment to safe, effective and efficient consumer product testing, Radiant Research staffs clinical coordinators, recruitment specialists, technicians and medical research specialists at each site. Additionally, the sites are supported by a central team of experienced professionals who provide resources that are unmatched in the industry.
In addition to the wide range of claim support studies, Radiant Research has expanded its Dermal Safety testing to include the following: Cumulative Irritation, Phototoxicity, Contact Sensitization, Primary Irritation, Photoallergy and Transdermal Delivery Systems at multiple locations.
Radiant Research encourages those with consumer product testing needs to visithttp://www.radiantresearch.com and contact Charley Folk at 480-699-3406 or [email protected].
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.